Impact of AI in Healthcare and Its Effects by 2030

References

[1] DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2020). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20-33. https://doi.org/10.1016/j.jhealeco.2020.01.004

[2] Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017). Artificial intelligence in healthcare: Past, present and future. Stroke and Vascular Neurology, 2(4), 230-243. https://doi.org/10.1136/svn-2017-000101

[3] Mathaiyan, J. (2020). Artificial intelligence in drug discovery and development. International Journal of Pharmacy and Pharmaceutical Sciences, 12(4), 1-6. https://doi.org/10.22159/ijpps.2020v12i4.37022

[4] Nundy, S., Montgomery, T., & Wachter, R. M. (2019). Promoting trust between patients and physicians in the era of artificial intelligence. JAMA, 322(6), 497-498. https://doi.org/10.1001/jama.2019.10340

[5] Schuhmacher, A., Gassmann, O., & Hinder, M. (2020). Changing R&D models in research-based pharmaceutical companies. Journal of Translational Medicine, 14(1), 1-9. https://doi.org/10.1186/s12967-016-0838-4

[6] Shaban-Nejad, A., Michalowski, M., Buckeridge, D. L., & Peak, A. (2018). Artificial intelligence-assisted approaches for disease surveillance and response. Frontiers in Public Health, 6, 244. https://doi.org/10.3389/fpubh.2018.00244

[7] Tiulpin, A., Klein, S., Bierma-Zeinstra, S., Thevenot, J., Raine, R., & van der Heijde, D. (2021). Machine learning for osteoarthritis: Diagnosis, treatment, and monitoring. Nature Reviews Rheumatology, 17(1), 1-15. https://doi.org/10.1038/s41584-020-00516-2

[8] Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., & Gerber, S. I. (2021). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564-1567. https://doi.org/10.1056/NEJMc2004973

[9] Xiang, Y., Ng, K. P., & Ho, B. (2020). Artificial intelligence in medical imaging. Journal of the American College of Radiology, 17(5), 673-685. https://doi.org/10.1016/j.jacr.2019.11.013

[10] Esteva, A., et al. (2021). Deep learning-enabled medical image analysis: Advances and applications. Nature Medicine, 27(8), 1370-1381.

[11] Mesko, B. (2020). The role of artificial intelligence in reshaping healthcare professions. Future Healthcare Journal, 7(2), 94-98.

[12] Nguyen, T., et al. (2020). The rise of AI in telemedicine: Transforming healthcare delivery. Journal of Telemedicine and Telecare, 26(10), 626-632.

[13] Rahmani, A., et al. (2022). AI and wearable technology for preventive healthcare: Opportunities and challenges. IEEE Transactions on Biomedical Engineering, 69(4), 1023-1035.

[14] Russell, S., et al. (2021). AI and pandemic preparedness: Lessons from COVID-19. The Lancet Digital Health, 3(7), e437-e448.

[15] Torous, J., et al. (2021). Digital mental health interventions: AI-powered solutions and their challenges. Psychiatric Services, 72(5), 526-533.

[16] Zhou, Y., et al. (2022). AI in drug discovery: A roadmap for the future. Nature Reviews Drug Discovery, 21(3), 202-217.

@article{1707774,
      author = {Ebele Precious Okemba, Onwuegbuchulam C. O},
      title = {Impact of AI in Healthcare and Its Effects by 2030},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {10},
      pages = {136-141},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1707774.pdf},
      abstract = {Artificial Intelligence (AI) is rapidly transforming various sectors, with healthcare being one of the most promising areas of application. AI-driven technologies have demonstrated the potential to revolutionize healthcare by improving diagnostic accuracy, optimizing treatment plans, accelerating medical research, and enhancing overall healthcare efficiency. This paper explores the role of AI in healthcare, examining its impact on disease detection, predictive analytics, and drug development. By analysing advancements in machine learning, deep learning, natural language processing, and robotics, the study highlights how AI contributes to personalized medicine and faster, more effective patient care. Despite its significant benefits, AI implementation in healthcare faces challenges, including data availability, algorithmic bias, and ethical concerns. To fully harness AI?s potential, increased investment in research, interdisciplinary collaboration, and regulatory frameworks are required. As AI continues to evolve, its integration into healthcare will become increasingly crucial in addressing global medical challenges and improving patient outcomes by 2030.},
      keywords = {Artificial Intelligence, Healthcare, Machine Learning, Drug Discovery, Driven Diagnosis, Clinical Decision Making.},
      month = {April},
  }